Clinical Trial Update: The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating GLP-1 agonists versus oral contraceptives on reproductive disorders and cardiovascular risks in overweight individuals with polycystic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Polycystic Ovary Syndrome

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Polycystic Ovary Syndrome (PCOS), Overweight | Phase 4 | Status: COMPLETED | Results posted: 2023-12-04